Neurosciences articles for University of California, San Francisco (UCSF), United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 59

Article ‘Count’ for Neurosciences.

Journal Count Share
1 0.14
Action Collaborative on Traumatic Brain Injury Care: Adapted Clinical Practice Guideline 0.14
14 2.49
Genetic‐Proteomic Integration Identifies Predictive Plasma Proteins for Multiple Sclerosis 0.17
Multimorbidity and Associations with Cognition and Alzheimer's Disease Biomarkers 0.25
Primary Lateral Sclerosis Natural History Study: Primary Lateral Sclerosis Functional Rating Scale and Other Outcomes Assessment 0.03
Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling 0.18
Tau Pathology in Alzheimer's Disease Uniquely Affects Sulcal Depths 0.27
Real‐World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease‐Modifying Therapy in Pediatric Multiple Sclerosis 0.11
Mutations in the Key Autophagy Tethering Factor scpEPG5/scp Link Neurodevelopmental and Neurodegenerative Disorders Including Early‐Onset Parkinsonism 0.02
scpMarkVCID2/scp Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics 0.02
Randomized, Double‐Blind, Placebo‐Controlled, Multiple‐Dose Studies to Assess the Safety and Efficacy of Elezanumab when Added to Standard of Care in Relapsing and Progressive Forms of Multiple Sclerosis 0.14
Intravenous Glyburide in Medical and Endovascular‐Treated Large‐Core Stroke: A Subgroup Analysis of the scpCHARM/scp Randomized Clinical Trial 0.06
Toward a Universal Map of EEG: A Semantic, Low‐Dimensional Manifold for scpEEG/scp Classification, Clustering, and Prognostication 0.10
Sex Differences in Associations of Lewy Body Disease with Alzheimer's Disease and Cognitive Decline 0.17
High‐Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis 0.86
Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia 0.11
2 0.86
Aberrant striatal firing mediates impulsive decision-making in a mouse model of Parkinson’s disease 0.75
Occludin modulates HIV and ischaemic stroke response via mitochondrial antiviral signalling pathway 0.11
4 1.34
Physiological brain clearance architecture revealed by neuronal protein tracing 0.21
A cell type-specific mechanism driving the rapid antidepressant effects of transcranial magnetic stimulation 0.02
CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis 0.69
Cell-type-directed network-correcting combination therapy for Alzheimer’s disease 0.43
1 0.01
Electroencephalogram Features Distinguish Cases of Cerebral Malaria Among Malawian Children With Fever and Coma 0.01
1 0.08
Exposure to low-dose ionizing radiation and dementia mortality in Canadian nuclear power plant workers 0.08
1 0.13
Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition 0.13
1 0.07
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity 0.07
1 0.94
Longevity factor klotho and resistance to cognitive deficits in individuals with Parkinson’s disease and in an α-synuclein mouse model 0.94
1 0.03
Design of Tau Aggregation Inhibitors Using Iterative Machine Learning and a Polymorph-Specific Brain-Seeded Fibril Amplification Assay 0.03
1 0.15
Cell autonomous microglia defects in a stem cell model of frontotemporal dementia tau 0.15
3 0.16
Parkinson’s disease as a somato-cognitive action network disorder 0.09
Ageing promotes microglial accumulation of slow-degrading synaptic proteins 0.02
Increased CSF drainage by non-invasive manipulation of cervical lymphatics 0.05
11 2.61
Single-nucleus epigenomic dysregulation unmasks genetic risk-associated neurodegenerative glia states 0.32
Seed structure and phosphorylation in the fuzzy coat impact tau seeding competency 0.05
Fate mapping of peripherally-derived macrophages after traumatic brain injury in mice reveals a long-lasting population with a distinct transcriptomic signature 0.05
Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer’s Disease 0.06
CSF total tau as a proxy of synaptic degeneration 0.01
Distinct manifestations of excitatory-inhibitory imbalance associated with amyloid-β and tau in patients with Alzheimer’s disease 0.88
Reduction of neuronal activity mediated by blood-vessel regression in the adult brain 0.05
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease 0.01
Brain-wide input-output analysis of tuberal nucleus somatostatin neurons reveals hierarchical circuits for orchestrating feeding behavior 0.03
Variable and interactive effects of Sex, APOE ε4 and TREM2 on the deposition of tau in entorhinal and neocortical regions 0.25
Boundary complexity of cortical and subcortical areas predicts deep brain stimulation outcomes in Parkinson’s disease 0.90
2 0.89
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration 0.03
Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis 0.85
2 0.97
Laminar organization of cellular microcircuits modulating human interictal epileptiform discharges 0.94
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, genotype and sex 0.03
3 1.38
A dorsal hippocampus-prodynorphinergic dorsolateral septum-to-lateral hypothalamus circuit mediates contextual gating of feeding 0.06
Restoration of temporal separability between beta and movement ensemble co-firing with motor recovery 0.38
G-protein-coupled receptor ADGRG1 drives a protective microglial state in Alzheimer's disease through MYC activation 0.94
2 0.93
Preservation of anticorrelated brain networks predicts recovery after traumatic brain injury 0.05
Keratinocyte–TRPV1 sensory neuron interactions in a genetically controllable mouse model of chronic neuropathic itch 0.88
3 0.62
CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology 0.15
Dopamine and serotonin cotransmission filters striatonigral synaptic activity via 5-HT1B receptor activation 0.17
Excitotoxic neuronal death requires superoxide entry into neurons through volume-regulated anion channels 0.30
1 0.06
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis 0.06
3 0.34
Alzheimer's disease neuropathology plasma biomarkers and cognition in midlife: a community-based cohort study 0.29
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication 0.02
Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial 0.04
1 0.06
Zorevunersen in Children and Adolescents with Dravet Syndrome 0.06

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.